Replies to post #206037 on Biotech Values

[DewDiligence]

ABT derives a higher proportion of sales and profits from ex-US than any other multinational drug/biotech/medical-device company. So, CEO Miles White is clearly betting that there won’t be a trade war.

I agree with White, as noted in #msg-126442202.

[DewDiligence]

ABT EVP buys $500K of stock on open market:

https://www.sec.gov/Archives/edgar/data/1800/000117911016033129/xslF345X03/edgar.xml

Not as dramatic as CEO, Miles White’s $61M buys in Aug and Nov 2016 (#msg-126536342, #msg-124155254), but a bullish signal nonetheless.